991 results on '"Shao, Zhi-Ming"'
Search Results
2. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients
3. Ipsilateral breast tumor recurrence after breast-conserving surgery: insights into biology and treatment
4. Radiomics in breast cancer: Current advances and future directions
5. Intratumor heterogeneity in breast cancer: Tracing its origins and translating findings into clinical practice
6. Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2A
7. DUSP4 enhances therapeutic sensitivity in HER2-positive breast cancer by inhibiting the G6PD pathway and ROS metabolism by interacting with ALDOB
8. Molecular classification of hormone receptor-positive HER2-negative breast cancer
9. Deep learning framework for comprehensive molecular and prognostic stratifications of triple-negative breast cancer
10. Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities
11. Single-cell morphological and topological atlas reveals the ecosystem diversity of human breast cancer
12. Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer
13. Calcifications in triple-negative breast cancer: Molecular features and treatment strategies
14. High expression of TLR3 in triple-negative breast cancer predicts better prognosis—data from the Fudan University Shanghai Cancer Center cohort and tissue microarrays
15. SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches
16. Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial
17. Clinical sequencing defines the somatic and germline mutation landscapes of Chinese HER2-Low Breast Cancer
18. Genetic interactions reveal distinct biological and therapeutic implications in breast cancer
19. CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltration
20. Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancer
21. Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
22. AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib versus letrozole plus palbociclib for previously untreated ER+/HER2– advanced breast cancer
23. Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria
24. Emerging therapies in cancer metabolism
25. Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?
26. CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancer
27. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials
28. A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer
29. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
30. Artificial intelligence-based diagnosis of breast cancer by mammography microcalcification
31. Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting the TOLLIP-mediated autophagic degradation of CIP2A
32. Adjuvant chemotherapy guided by an integrated mRNA–lncRNA signature in triple-negative breast cancer (BCTOP-T-A01): A randomized, open-label, multicenter phase 3 trial.
33. The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer
34. The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target
35. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
36. Comments on: a prediction model for distant metastasis after isolated locoregional recurrence of breast cancer
37. Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
38. O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression
39. A comprehensive genomic and transcriptomic dataset of triple-negative breast cancers
40. Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis
41. Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial
42. Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
43. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
44. Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era.
45. Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection.
46. SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1‐Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC.
47. Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens
48. Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer
49. Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis
50. Elongin B promotes breast cancer progression by ubiquitinating tumor suppressor p14/ARF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.